Journal of Histochemistry and Cytochemistry, Vol. 51, 1041-1048, August 2003, Copyright © 2003, The Histochemical Society, Inc.
Expression of GRP and Its Receptor in Well-differentiated Colon Cancer Cells Correlates with the Presence of Focal Adhesion Kinase Phosphorylated at Tyrosines 397 and 407
Kristina A. Matkowskyja,
Kristin Kellera,
Sarah Glovera,
Lori Kornbergc,
Roger Tran-Son-Tayb, and
Richard V. Benyaa,d
a Department of Medicine, University of Illinois at Chicago and Chicago Veterans Administration Medical Center (West Side Division), Chicago, Illinois
b Departments of Aerospace Engineering, University of Florida, Gainesville, Florida
c Otolaryngology, University of Florida, Gainesville, Florida
d Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois
Correspondence to:
Richard V. Benya, Dept. of Medicine, U. of Illinois at Chicago, 840 South Wood Street (M/C 716), Chicago, IL 60612. E-mail: rvbenya@uic.edu
Gastrin-releasing peptide (GRP) and its receptor (GRP-R) are not normally expressed by epithelial cells lining the colon but are aberrantly expressed in cancer, where they act as morphogens and regulate tumor cell differentiation. Studies of colon cancer formation in mice genetically incapable of synthesizing GRP-R suggested that this receptor's morphogenic properties were mediated via focal adhesion kinase (FAK). We therefore set out to determine the presence of both total and phosphorylated forms of FAK in human colon cancer specimens as a function of tumor cell differentiation and GRP/GRP-R co-expression. Ten colon cancers containing 25 regions of distinct differentiation were randomly selected from our GI Cancer Tumor Bank. All specimens were immunohistochemically probed using antibodies recognizing GRP, GRP-R, total FAK, and FAK specifically phosphorylated at tyrosine (Y) 397, 407, 576, 577, 861, and 925. Antibody-specific chromogen was determined by quantitative immunohistochemistry (IHC) for each region of defined differentiation. Here we confirm that GRP/GRP-R co-expression is a function of differentiation, with highest levels observed in well-differentiated tumor cells. We also show that the amount of total FAK and of FAK phosphorylated at Y397 and Y407 tightly correlates with differentiation and with the amount of GRP/GRP-R co-expression. These findings are consistent with GRP/GRP-R acting as a morphogen by activating FAK, and suggest that this occurs via phosphorylation of this enzyme at two specific tyrosine residues.
(J Histochem Cytochem 51:10411048, 2003)
Key Words:
bombesin, colorectal cancer, gastrin-releasing peptide, receptor

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Sakurama, K. Noma, M. Takaoka, Y. Tomono, N. Watanabe, S. Hatakeyama, O. Ohmori, S. Hirota, T. Motoki, Y. Shirakawa, et al.
Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
Mol. Cancer Ther.,
January 1, 2009;
8(1):
127 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Walsh, D. R. Ampasala, J. Hatfield, R. Vander Heide, S. Suer, A. K. Rishi, and M. D. Basson
Transforming Growth Factor-{beta} Stimulates Intestinal Epithelial Focal Adhesion Kinase Synthesis via Smad- and p38-Dependent Mechanisms
Am. J. Pathol.,
August 1, 2008;
173(2):
385 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Watanabe, M. Takaoka, K. Sakurama, Y. Tomono, S. Hatakeyama, O. Ohmori, T. Motoki, Y. Shirakawa, T. Yamatsuji, M. Haisa, et al.
Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo
Clin. Cancer Res.,
July 15, 2008;
14(14):
4631 - 4639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Matusiak and R. V. Benya
CYP27A1 and CYP24 Expression as a Function of Malignant Transformation in the Colon
J. Histochem. Cytochem.,
December 1, 2007;
55(12):
1257 - 1264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya
Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase
Am J Physiol Gastrointest Liver Physiol,
January 1, 2007;
292(1):
G182 - G190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Basson, M. A. Sanders, R. Gomez, J. Hatfield, R. VanderHeide, V. Thamilselvan, J. Zhang, and M. F. Walsh
Focal adhesion kinase protein levels in gut epithelial motility.
Am J Physiol Gastrointest Liver Physiol,
September 1, 2006;
291(3):
G491 - G499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Matusiak, G. Murillo, R. E. Carroll, R. G. Mehta, and R. V. Benya
Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in Normal and Malignant Human Colon
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2005;
14(10):
2370 - 2376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya
Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling
Am J Physiol Gastrointest Liver Physiol,
June 1, 2005;
288(6):
G1274 - G1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2003
|
|
|